Rosalind McAlpine

Profile photo of Rosalind McAlpine
Rosalind completed her BA in Experimental Psychology at Oxford University, where she specialised in neuroscience, social psychology, and developmental questions in science and religion. She then completed her MRes in Developmental Neuroscience and Psychopathology at UCL, followed by a year working as a Post-Graduate Research Fellow at Yale University. In her rotational year she will be working on projects with (1) Sunjeev Kamboj/Vaughan Bell, (2) David Osborn and (3) Ray Dolan/Rani Moran. She is interested in research focusing on the development of novel psychological and/or pharmacological treatments within clinical psychology (e.g., psychedelic research); a venture which necessitates interdisciplinary collaboration, encompassing neuroscience, psychopharmacology, social-psychological theory and policy. She is particularly interested in mechanisms of action, as well as comparisons between the use of psychedelic substances in traditional/ceremonial retreat settings and their place in Western psychiatric models. She considers the development of effective prevention and treatment strategies - with emphasis on the requirement of increased cultural competency - incredibly important if we are to progress within mental health science.


Follow me here –

Ketamine “shows promise” as an anti-suicidal ideation agent, but will this promise ever be realised?


Rosalind McAlpine and Karel Kieslich summarise a recent systematic review which focuses on the rapid anti-suicidal ideation effect of ketamine.

[read the full story...]

Suicide rates in the early stages of the COVID-19 pandemic: cross-national data provide no evidence of an increase


Karel Kieslich, Rosalind McAlpine and Alexandra Pitman review a recent study exploring suicide trends in the early months of the COVID-19 pandemic with real-time data from 21 countries.

[read the full story...]